Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ABEO

Abeona Therapeutics (ABEO)

Abeona Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABEO
DateTimeSourceHeadlineSymbolCompany
04/02/202512:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
04/02/202512:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
04/02/202512:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
04/02/202512:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
04/02/202512:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
04/02/202512:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
04/02/202512:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
03/02/202523:30GlobeNewswire Inc.Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ABEOAbeona Therapeutics Inc
01/02/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
30/01/202508:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
24/01/202510:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
24/01/202510:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
24/01/202510:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
22/01/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
22/01/202508:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ABEOAbeona Therapeutics Inc
07/01/202509:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ABEOAbeona Therapeutics Inc
31/12/202423:30GlobeNewswire Inc.Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ABEOAbeona Therapeutics Inc
21/12/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABEOAbeona Therapeutics Inc
02/12/202423:30GlobeNewswire Inc.Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ABEOAbeona Therapeutics Inc
15/11/202411:56Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ABEOAbeona Therapeutics Inc
15/11/202401:59Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ABEOAbeona Therapeutics Inc
14/11/202423:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABEOAbeona Therapeutics Inc
14/11/202423:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABEOAbeona Therapeutics Inc
14/11/202423:30GlobeNewswire Inc.Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate UpdatesNASDAQ:ABEOAbeona Therapeutics Inc
13/11/202409:24Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ABEOAbeona Therapeutics Inc
12/11/202423:30GlobeNewswire Inc.Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis BullosaNASDAQ:ABEOAbeona Therapeutics Inc
04/11/202423:30GlobeNewswire Inc.Abeona Therapeutics® Announces Participation in November Investor ConferencesNASDAQ:ABEOAbeona Therapeutics Inc
01/11/202422:30GlobeNewswire Inc.Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ABEOAbeona Therapeutics Inc
29/10/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABEOAbeona Therapeutics Inc
29/10/202422:30GlobeNewswire Inc.Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug AdministrationNASDAQ:ABEOAbeona Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ABEO